Hashemian Seyed Javad, Farrokhi Hosein, Foroutan Alireza, Jafari Mohammad Ebrahim, Hashemian Seyed Mahyar, Alemzadeh Sayyed Amirpooya, Hashemian Mahsa Sadat
Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Curr Ophthalmol. 2017 Nov 10;30(2):136-141. doi: 10.1016/j.joco.2017.10.002. eCollection 2018 Jun.
To investigate the changes in higher-order aberrations (HOAs) induced by the implantation of implantable collamer lenses (ICLs) and Toric ICL (TICL) in eyes with high myopia and high myopic astigmatism.
We investigated 33 eyes of 18 consecutive patients (in a prospective, interventional case series study), with spherical equivalent errors of -6.00 to -21.09 diopters (D) and cylindrical errors of -0.5 to -4.75 D, who underwent ICL and TICL implantation. Before and after 5 days, 2 and 6 months of surgery, the uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), defocus and adverse events of the surgery were assessed. Ocular HOAs were also evaluated by Hartmann-Shack aberrometry (Technolas PV, Rochester, New York, USA) before and after 6 months of surgery.
At 6.0 months after surgery, the UCVA and BCVA in 40% and 66.7% of eyes were 20/20, respectively. Mean defocus refraction and astigmatism was reduced to -0.66 and 0.65 D from -12.79 and 2.18 at baseline, respectively. For a 6 mm pupil, HOAs were not significantly changed, merely from 0.417 ± 0.162 μ before surgery to 0.393 ± 0.119 μ after surgery (P = 0.45). Spherical aberration (Z400) increased significantly (P = 00.0). Surgical induced astigmatism was lower than 0.25 D, and there were no changes in trefoils and coma aberration. No vision-threatening complications occurred during the observation period.
This study shows that the ICL and TICL performed well in correcting high myopic astigmatism without significant changes in HOAs during a 6-month observation period, although the spherical aberration (Z400) increased significantly.
研究植入可植入式胶原晶状体(ICL)和散光型可植入式胶原晶状体(TICL)对高度近视和高度近视散光眼高阶像差(HOA)的影响。
我们对18例连续患者的33只眼进行了研究(前瞻性干预病例系列研究),这些患者的等效球镜度误差为-6.00至-21.09屈光度(D),柱镜度误差为-0.5至-4.75 D,均接受了ICL和TICL植入手术。在手术前、术后5天、2个月和6个月,评估未矫正视力(UCVA)、最佳矫正视力(BCVA)、散焦情况及手术不良事件。术后6个月前后还通过Hartmann-Shack像差仪(美国纽约罗切斯特的Technolas PV)评估眼HOA。
术后6.0个月时,40%的眼睛UCVA和66.7%的眼睛BCVA达到20/20。平均散焦屈光和散光分别从基线时的-12.79和2.18 D降至-0.66和0.65 D。对于6 mm瞳孔,HOA无显著变化,仅从手术前的0.417±0.162 µm变为手术后的0.393±0.119 µm(P = 0.45)。球差(Z400)显著增加(P = 0.00)。手术诱导的散光低于0.25 D,三叶像差和彗差无变化。观察期内未发生威胁视力的并发症。
本研究表明,ICL和TICL在矫正高度近视散光方面表现良好,在6个月观察期内HOA无显著变化,尽管球差(Z400)显著增加。